Scalable automation for cell and gene therapy

DNA / RNA

Scalable automation for cell and gene therapy

02 Mar, 2026

Celltrio advances automated life science workflows with a modular platform supporting allogeneic and autologous cell and gene therapy from research through GMP manufacturing. Built on a common automation backbone, RoboCell™ configurations adapt to specific culture formats, process requirements, and regulatory environments.

RoboCell Mito™ delivers compact automation for T-flask culturing, while RoboCell GMP™ extends the same architecture into GMP-aligned environments for controlled, documented manufacturing. RoboCell Suspension™ supports TubeSpin® and Erlenmeyer flasks, integrating automated handling, shaking incubation, and environmental control for scalable suspension cell expansion.

RoboStor™ complements the platform with automated vapour-phase LN₂ biobanking. Its Mini-Cryo-Chamber enables controlled-rate freezing and individual cryovial handling while maintaining sample temperatures at approximately -135°C to preserve cryogenic integrity.

Together, Celltrio delivers configurable, scalable automation aligned to biology, workflow complexity, and compliance requirements.

More information online

Latest News

Lab Asia 33.4 - August 2026

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
Environmental sample extraction: moving beyond the limitations of EPA Method 3546
Explore more Arrow
Pollution Solutions Online
Leading UK biogas operator places first orders for new FlowSep technology
Explore more Arrow
Petro Online
What happens when a refinery suddenly stops?
Explore more Arrow
Chromatography Today
UHPLC–MS/MS methodology detects multiple algal toxins in fish plasma
Explore more Arrow